

Jon Evans
Chair, Senior Associate, OPEN MINDS, Telehealth Founder, Co-Founder, OCEO, Past Founder & Chief Executive Officer, InnovaTel Telepsychiatry
Turning Health Innovation Into Impact
The annual OPEN MINDS Investment Pitch Day will occur on June 10, 2026, at The 2026 OPEN MINDS Strategy & Innovation Institute. Each organization selected to present offers a unique solution to the high-needs consumer marketplace and is looking to accelerate their growth through strategic investments and partnerships. The event will be hosted by Jonathan Evans, Operating Partner at Empactful Capital, Senior Associate at OPEN MINDS, and former Chief Executive Officer of innovaTel Telepsychiatry.
During the event, a panel of investors will evaluate each pitch and will decide a winner based on the solution that they find most investible!

Applications are reviewed by an industry-specific advisory board and scored based on the following criteria:
- Area of focus
- Impact metrics
- Business traction and growth
- Team strength
- Track record
- Potential market impact
All applications to present are due by February 20, 2026.
The 2026 Pitch Day Judges:
Aaron Baca

Aaron joined Vista Care in 2024 to help lead the development of the next wave of tech-enabled I/DD services. Before Vista Care, he founded Mox Capital, where he partnered with innovative healthcare companies focused on reducing costs and enhancing outcomes. Aaron also served as Head of Healthcare and Life Sciences at Kingfish Group, where he sourced investment opportunities and drove strategic growth for portfolio companies. He holds a BA from Stanford University and a Master’s Degree from Oxford University.
Sal DelTrane

Sal DeTrane co-founded Empactful Capital with a penchant for strategy, growth planning and operational execution, skill which he honed over his 25 years of experience spanning roles in venture capital, business development, organizational development, operations, and finance.
Sal’s passion for advising technology-focused, early and growth stage entrepreneurs came into focus when he moved to Silicon Valley in 1996. In late 2001, he co-founded Nucleus Partners to serve as a venture capital and catalyst firm for seed and early-stage technology businesses – it was here that Sal pioneered the approach of a “working engagement” diligence model. Sal led Nucleus’ investment in Mede Analytics, the nation’s largest privately held health care analytics business, a company which he went on to run for 12 years as the #2 executive. During this time, Sal gained valuable direct P&L and operational experience. He was instrumental in Mede’s revenue growth in both the hospital and payer markets. This market/product strategy led to Mede’s growth from $3 million to over $120 million in revenues. Thoma Bravo acquired Mede as it prepared for its IPO in 2015.
Prior to Nucleus, Sal co-managed nearly $50 million of committed capital at The Angels’ Forum after successfully building a technology investment banking practice in Silicon Valley.
Bolstered by a history of developing and managing relationships across the healthcare ecosystem, Sal sits on the boards of several early/growth stage healthcare IT companies.
A die-hard Philly sports fan, Sal currently splits his time between Bucks County, PA and the Bay Area. Sal graduated Summa Cum Laude with his B.S. in Business Administration, with an emphasis in Accounting, from Temple University. Sal currently serves on Temple University’s President’s Council and the Dean’s Council for the Fox Business School where he is also assisting with the development of a Venture Capital and Private Equity Institute.
Tania S. Malik, J.D.

As co-founder of The Office of CEO, Tania brings a 25-year success record of C-level leadership, board experience, interim executive engagements, consultancy, investor experience, and serial entrepreneurship with multiple successful exits. Over the course of her career, she has realized several industry firsts as she launched several telemedicine companies starting in 1999. She is the Founder or Co-Founder of Medical Web, Inc, Virtual Medical Group, Inc. 1stonlinepharmacy.com (all related to online primary care with Medical Web being acquired), Vital Health Network. LLC (an online naturopathic company that implemented with Aetna), COPE Today, LLC (a telemental health company acquired by a venture firm), Virtual Medical Services and Veteran Benefit Management Services (dedicated to providing Independent Medical Opinions for veterans).
After two exits, she pivoted to board work, consultancy, and investments.
She serves as executive advisor to Excelerate Health Ventures (focusing on health SAAS companies) and member of Triangle Angel Partners (includes companies outside of healthcare).
As COO of the Center of Digital Health, Innovation and Telehealth for Optum, she focused on a virtual-first care delivery model. She also served as a strategic advisory board member for OmnySense, Inc. and Innovatel Telepsychiatry, acquired by Quartet Health in 2021. As co-founder and CEO of Medical Web, she led the first-of-its-kind online physician-patient communication platform to acquisition in 2014. She also served on the Board of Directors for Mindcare Solutions Group upon its 2013 acquisition of COPE Today, and is currently serving on the Board of Directors for Planned Parenthood Direct and other non-profit boards. She is a Fellow in the American Telemedicine Association (ATA) College of Fellows and was the ATA Woman of the Year in 2020.
Early in her career, Tania practiced law as a Senior Enforcement Attorney with the Commissioner of Insurance for the State of Georgia, and held the position of Administrative Law Judge with the Office of State Administrative Hearings (OSAH) as well as General Counsel for an HMO, Master Health Plan, Inc. A key tenure in management consulting with PricewaterhouseCoopers’ healthcare practice in Atlanta served as a launch pad for business and entrepreneurial opportunities across the healthcare space.
Tania holds a bachelor’s degree in political science from the University of North Carolina at Chapel Hill University, and a Doctor of Law from Georgia State University College of Law.
Steven J. Mason Jr., M.Ed.

Steven is a Managing Partner and healthcare industry veteran with more than 25 years of experience starting and operating market-leading technology and services companies in the health and human services industries.
He has been instrumental in Fund I’s investments, including Care Continuity, where he recently served as CEO. Prior to serving as Executive Vice President at Iodine, Steven was the Chief Executive Officer at ChartWise Medical Systems, Inc., a computer-assisted clinical documentation system company that automated and improved the completeness and accuracy of physician documentation for faster and more optimal reimbursement of services provided. Iodine acquired ChartWise in 2021.
​Prior to his success with ChartWise, he led several successful start-up ventures including OnFocus Healthcare, a leading provider of web-based enterprise performance management software solutions for healthcare providers and payers. The company was acquired by MedeAnalytics, where he was Senior Vice President and General Manager of the EPM Business Unit. In this role, Steven was primarily responsible for integrating, managing, and growing the Mede Performance Management (MedePM) business unit within the broader MedeAnalytics portfolio.
Â
Additionally, he was Co-Founder, President and Chief Executive Officer of Qualifacts Systems, a SaaS based electronic medical records software provider, and Chief Operating Officer of Camelot Care Centers, a national behavioral healthcare provider organization.
Steven received his BA in History from the University of Mississippi and an M.Ed. Human and Organizational development / counseling from Vanderbilt University. Mr. Mason currently serves on the Board of Directors of several private digital health companies.
Prize Package
- OPEN MINDS Press Package
- An OPEN MINDS 2026/2027 Partnership Package
- A Knowledge Partner speaking session at an upcoming 2026 or 2027 institute of your choice
Prize valued at over $40,000!
Attendance for the OPEN MINDS Investment Pitch Day is included in The 2026 OPEN MINDS Strategy & Innovation Institute, June 9-11, 2026. Use the “Register To Attend” button to secure your spot. Space is limited for this competitive opportunity!
Please email edeppen@openminds.com for more information.

